0001104659-22-084835.txt : 20220801
0001104659-22-084835.hdr.sgml : 20220801
20220801180054
ACCESSION NUMBER: 0001104659-22-084835
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220624
FILED AS OF DATE: 20220801
DATE AS OF CHANGE: 20220801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DRISCOLL FREDERICK W
CENTRAL INDEX KEY: 0001129890
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36598
FILM NUMBER: 221126142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cellectar Biosciences, Inc.
CENTRAL INDEX KEY: 0001279704
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043321804
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CAMPUS DRIVE
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: (608) 441-8120
MAIL ADDRESS:
STREET 1: 100 CAMPUS DRIVE
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
FORMER COMPANY:
FORMER CONFORMED NAME: NOVELOS THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20050617
FORMER COMPANY:
FORMER CONFORMED NAME: COMMON HORIZONS INC
DATE OF NAME CHANGE: 20040211
4
1
tm2222253-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-06-24
0
0001279704
Cellectar Biosciences, Inc.
CLRB
0001129890
DRISCOLL FREDERICK W
C/O CELLECTAR BIOSCIENCES, INC.
100 CAMPUS DRIVE
FLORHAM PARK
NJ
07932
1
0
0
0
Stock option (right to buy)
4.10
2022-06-24
4
A
0
7800
0
A
2032-06-24
Common Stock
7800
7800
D
Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022.
This stock option shall vest in full on June 24, 2023, subject to the reporting person's continued service through the applicable vesting date.
/s/ Christina Blakley, attorney-in-fact for Frederick Driscoll
2022-08-01